Ogura Kanako, Ishi Kazuhisa, Matsumoto Toshiharu, Kina Katsunari, Nojima Michio, Suda Koichi
Department of Pathology (I), School of Medicine, Juntendo University, Tokyo, Japan.
Pathol Int. 2006 Jun;56(6):301-8. doi: 10.1111/j.1440-1827.2006.01964.x.
Many studies have suggested that human papillomavirus (HPV) infection plays an important role in the carcinogenesis of the cervical adenocarcinoma. However, the prevalence of HPV infection in cervical adenocarcinoma and adenosquamous carcinoma varies among the studies. Cervical adenocarcinoma (24 cases) and adenosquamous carcinoma (16 cases), including the underlying non-neoplastic epithelium were examined for HPV-DNA using in situ polymerase chain reaction (PCR), which enabled visualization of the localization on a glass slide. In adenocarcinoma, HPV-DNA was found in 13 cases (54%) and in eight cases in underlying non-neoplastic epithelium, resulting in a total of 21 positive cases (88%). In adenosquamous carcinoma, HPV-DNA was detected in 12 cases (75%) and and the HPV-DNA localization of each component was pure adenocarcinoma, 28.6%; mixed, 54.5%; and pure squamous cell carcinoma, 83.3%. In the underlying non-neoplastic epithelium, HPV-DNA was found more frequently in the squamous epithelium (73.3%) than the cervical glands (6.3%). In conclusion, HPV-DNA was detected in 54% of adenocarcinoma, and the rate was elevated by HPV localization in the underlying non-neoplastic epithelium. HPV infection in the underlying squamous epithelium might be related to the carcinogenesis, even in cervical adenocarcinoma. HPV-DNA localization was different in each component of adenosquamous carcinoma.
许多研究表明,人乳头瘤病毒(HPV)感染在宫颈腺癌的致癌过程中起重要作用。然而,不同研究中宫颈腺癌和腺鳞癌中HPV感染的患病率有所不同。采用原位聚合酶链反应(PCR)对24例宫颈腺癌和16例腺鳞癌(包括其下方的非肿瘤性上皮)进行HPV-DNA检测,该方法能够在载玻片上直观显示其定位。在腺癌中,13例(54%)检测到HPV-DNA,8例在下方的非肿瘤性上皮中检测到,共计21例阳性(88%)。在腺鳞癌中,12例(75%)检测到HPV-DNA,且各成分的HPV-DNA定位情况为:纯腺癌占28.6%;混合性占54.5%;纯鳞状细胞癌占83.3%。在下方的非肿瘤性上皮中,HPV-DNA在鳞状上皮中的检出率(73.3%)高于宫颈腺(6.3%)。总之,54%的腺癌中检测到HPV-DNA,且下方非肿瘤性上皮中的HPV定位使该比例升高。即使在宫颈腺癌中,下方鳞状上皮中的HPV感染可能也与致癌作用有关。腺鳞癌各成分中的HPV-DNA定位不同。